Both parties want to crack down on pharmacy benefit managers. The vice president could help get it done.
prescription drugs
Posted inTAP
FTC Comes for PBMs
Today on TAP: An interim report shows how pharmaceutical middlemen raise drug prices and damage care.
Posted inHealth and Social Policy
New Bill Seeks to End Drug Shortages
The Senate Finance Committee wants to create a new program to incentivize better practices. Critics say there’s an easier way: end kickbacks between suppliers and bulk purchasers.
Posted inHealth and Social Policy
Our Uniquely American Drug Shortages
More drugs are in short supply than ever before. We’ve known the reason why for a long time: monopolistic middlemen.
Posted inMoney, Politics, and Power
Senators’ Latest Attempt to Enrich Big Pharma Must Not Prevail
Patents are meant to encourage actual innovation, not monster corporate profits.
Posted inHealth and Social Policy
The PBM-Insurer Mafia Comes for Community Pharmacies
UnitedHealth, CVS, and Cigna’s PBMs are using their market share and pull in Washington to drive one of the key levers to manage health care costs—independent pharmacies—out of business.
Posted inHealth and Social Policy
Novo Nordisk Discontinues Insulin Medication After Cutting Its Price
Levemir is critical for young people and pregnant women, patients say. But it won’t be sold in the U.S. after this year.
Posted inTAP
Drug Companies Are Fighting Biden’s Efforts to Lower Their Prices
Today on TAP: We should visibly fight back (good for Americans’ health and wallets, and good for Democrats’ prospects).
Posted inHealth and Social Policy
‘Return What You Stole and Be a Man With Dignity’
Doctors didn’t think it was possible to loathe the world’s biggest health care profiteer any more. Then came the hack that set half their bookkeeping systems on fire.
Posted inHealth and Social Policy
Controlling Birth Control
On the eve of over-the-counter birth control pills, the GOP can’t possibly convince Americans that the right to contraception is wrong.
